NBI

If this stock market is shaping up like 2008, here’s where we could be headed next, says strategist

Comparisons between 2022 and 2008 are making the rounds. Here's one look at what that might mean in the months ahead.

Achilles Therapeutics Added To NASDAQ Biotechnology Index As Of Dec. 20, 2021

Achilles Therapeutics plc (NASDAQ:ACHL), a clinical-stage biopharmaceutical company developing precision T cell therapies to treat solid tumors, today announced that the Company has been added to the NASDAQ Biotech Index

Psychedelics Company COMPASS Pathways To Join NASDAQ Biotechnology Index

Psilocybin-focused mental health care company COMPASS Pathways plc (NASDAQ: CMPS) revealed Friday that it has been selected for addition to the Nasdaq Biotechnology Index (NASDAQ: NBI), effective as of market open on Mon

Teknova To Join Nasdaq Biotechnology Index Effective Dec. 20, 2021

 Alpha Teknova, Inc. ("Teknova") (NASDAQ:TKNO), a leading provider of critical reagents for the development and production of biopharmaceutical products, including drug therapies, novel vaccines, and

Sera Prognostics Added To Nasdaq Biotechnology Index As Of Dec. 20, 2021

 Sera Prognostics Inc., The Pregnancy Company® (NASDAQ:SERA), focused on improving maternal and neonatal health by providing innovative pregnancy biomarker information to doctors and patients, today

The Daily Biotech Pulse: Lilly Raises Guidance, Medtronic Gets FDA Warning Letter, Decision Day For Calliditas, Genenta IPO

Here's a roundup of top developments in the biotech space over the last 24 hours.

ALX Oncology Added to the NASDAQ Biotechnology Index

ALX Oncology Holdings Inc., (“ALX Oncology”) (NASDAQ:ALXO) a clinical-stage immuno-oncology company developing therapies that block the CD47 checkpoint pathway, today announced that it has been selected for

Ovid Therapeutics Announces Addition to the Nasdaq Biotechnology Index

Ovid Therapeutics Inc. (NASDAQ:OVID), a biopharmaceutical company committed to developing medicines that transform the lives of people with rare neurological diseases, today announced that it has been added to the